Startup developing treatments for Tourette syndrome and stuttering raises $35M
A Chicago biotech startup that's developing treatments for central nervous system movement disorders raised a round of funding to bring its therapies to market.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Jim Dallke Source Type: news
More News: American Health | Biotechnology | Funding | Health Management | Stammer | Tourette Syndrome